Literature DB >> 25395450

Essential nutrient supplementation prevents heritable metabolic disease in multigenerational intrauterine growth-restricted rats.

Danielle Goodspeed1, Maxim D Seferovic1, William Holland1, Robert A Mcknight1, Scott A Summers1, D Ware Branch1, Robert H Lane1, Kjersti M Aagaard2.   

Abstract

Intrauterine growth restriction (IUGR) confers heritable alterations in DNA methylation, rendering risk of adult metabolic syndrome (MetS). Because CpG methylation is coupled to intake of essential nutrients along the one-carbon pathway, we reasoned that essential nutrient supplementation (ENS) may abrogate IUGR-conferred multigenerational MetS. Pregnant Sprague-Dawley rats underwent bilateral uterine artery ligation causing IUGR in F1. Among the F2 generation, IUGR lineage rats were underweight at birth (6.7 vs. 8.0 g, P < 0.0001) and obese by adulthood (p160: 613 vs. 510 g; P < 0.0001). Dual energy X-ray absorptiometry studies revealed increased central fat mass (Δ+40 g), accompanied by dyslipidemic (>30% elevated, P < 0.05) serum triglycerides (139 mg/dl), very-LDLs (27.8 mg/dl), and fatty acids (632 µM). Hyperglycemic-euglycemic clamp studies and glucose tolerance testing revealed insulin resistance. Conversely, IUGR lineage ENS-fed rats did not manifest MetS, with significantly lower body weight (p160: 410 g), >5-fold less central fat mass, normal hepatic glucose efflux, and >70% reduced circulating triglycerides and very-LDLs compared with IUGR control-fed F2 offspring (P < 0.01). Moreover, increased methylation of the IGF-1 P2 transcriptional start site among IUGR lineage F2 offspring was reversed in ENS (P < 0.04). This is an initial demonstration that supplementation along the one-carbon pathway abrogates adult morbidity and associated epigenomic modifications of IGF-1 in a rodent model of multigenerational MetS. © FASEB.

Entities:  

Keywords:  IGF-1; epigenomics; methyl donors; obesity; one-carbon pathway

Mesh:

Substances:

Year:  2014        PMID: 25395450      PMCID: PMC4422359          DOI: 10.1096/fj.14-259614

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  81 in total

Review 1.  Epigenetic reprogramming in mammals.

Authors:  Hugh D Morgan; Fátima Santos; Kelly Green; Wendy Dean; Wolf Reik
Journal:  Hum Mol Genet       Date:  2005-04-15       Impact factor: 6.150

2.  Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease.

Authors:  D J Barker; C Osmond; J Golding; D Kuh; M E Wadsworth
Journal:  BMJ       Date:  1989-03-04

3.  Epigenetics of programmed obesity: alteration in IUGR rat hepatic IGF1 mRNA expression and histone structure in rapid vs. delayed postnatal catch-up growth.

Authors:  Darran N Tosh; Qi Fu; Christopher W Callaway; Robert A McKnight; Isabella C McMillen; Michael G Ross; Robert H Lane; Mina Desai
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-09-02       Impact factor: 4.052

4.  Altered growth, hypoglycemia, hypoalaninemia, and ketonemia in the young rat: postnatal consequences of intrauterine growth retardation.

Authors:  E S Ogata; M E Bussey; A LaBarbera; S Finley
Journal:  Pediatr Res       Date:  1985-01       Impact factor: 3.756

5.  Caffeine-induced fetal rat over-exposure to maternal glucocorticoid and histone methylation of liver IGF-1 might cause skeletal growth retardation.

Authors:  Yang Tan; Jin Liu; Yu Deng; Hong Cao; Dan Xu; Fenglong Cu; Youying Lei; Jacques Magdalou; Min Wu; Liaobin Chen; Hui Wang
Journal:  Toxicol Lett       Date:  2012-09-17       Impact factor: 4.372

6.  IUGR alters postnatal rat skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator-1 gene expression in a fiber specific manner.

Authors:  Robert H Lane; Nicole K Maclennan; Monica J Daood; Jennifer L Hsu; Sara M Janke; Tho D Pham; Aarti R Puri; Jon F Watchko
Journal:  Pediatr Res       Date:  2003-03-19       Impact factor: 3.756

7.  Uteroplacental insufficiency alters DNA methylation, one-carbon metabolism, and histone acetylation in IUGR rats.

Authors:  Nicole K MacLennan; S Jill James; Stephan Melnyk; Ali Piroozi; Stefanie Jernigan; Jennifer L Hsu; Sara M Janke; Tho D Pham; Robert H Lane
Journal:  Physiol Genomics       Date:  2004-06-17       Impact factor: 3.107

8.  Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1.

Authors:  Jun H Park; Doris A Stoffers; Robert D Nicholls; Rebecca A Simmons
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

9.  Epigenetics: intrauterine growth retardation (IUGR) modifies the histone code along the rat hepatic IGF-1 gene.

Authors:  Qi Fu; Xing Yu; Christopher W Callaway; Robert H Lane; Robert A McKnight
Journal:  FASEB J       Date:  2009-04-13       Impact factor: 5.191

Review 10.  Soft tissue composition and bone mineral status: evaluation by dual-energy X-ray absorptiometry.

Authors:  H C Lukaski
Journal:  J Nutr       Date:  1993-02       Impact factor: 4.798

View more
  15 in total

1.  Programmed Epigenetic DNA Methylation-Mediated Reduced Neuroprogenitor Cell Proliferation and Differentiation in Small-for-Gestational-Age Offspring.

Authors:  Mina Desai; Guang Han; Tie Li; Michael G Ross
Journal:  Neuroscience       Date:  2019-05-31       Impact factor: 3.590

Review 2.  The growing problem of obesity: mechanisms, consequences, and therapeutic approaches.

Authors:  Ann Marie Schmidt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-06       Impact factor: 8.311

3.  Perinatal high fat diet and early life methyl donor supplementation alter one carbon metabolism and DNA methylation in the brain.

Authors:  Sarah E McKee; Sisi Zhang; Li Chen; Joshua D Rabinowitz; Teresa M Reyes
Journal:  J Neurochem       Date:  2018-04-16       Impact factor: 5.372

4.  Heritable IUGR and adult metabolic syndrome are reversible and associated with alterations in the metabolome following dietary supplementation of 1-carbon intermediates.

Authors:  Maxim D Seferovic; Danielle M Goodspeed; Derrick M Chu; Laura A Krannich; Pablo J Gonzalez-Rodriguez; James E Cox; Kjersti M Aagaard
Journal:  FASEB J       Date:  2015-03-10       Impact factor: 5.191

Review 5.  Epigenetic effects of the pregnancy Mediterranean diet adherence on the offspring metabolic syndrome markers.

Authors:  David Lorite Mingot; Eva Gesteiro; Sara Bastida; Francisco J Sánchez-Muniz
Journal:  J Physiol Biochem       Date:  2017-09-18       Impact factor: 4.158

6.  Methyl donor supplementation alters cognitive performance and motivation in female offspring from high-fat diet-fed dams.

Authors:  Sarah E McKee; Nicola M Grissom; Christopher T Herdt; Teresa M Reyes
Journal:  FASEB J       Date:  2017-02-16       Impact factor: 5.191

7.  Alterations in expression of imprinted genes from the H19/IGF2 loci in a multigenerational model of intrauterine growth restriction (IUGR).

Authors:  Pablo Gonzalez-Rodriguez; Jessica Cantu; Derek O'Neil; Maxim D Seferovic; Danielle M Goodspeed; Melissa A Suter; Kjersti M Aagaard
Journal:  Am J Obstet Gynecol       Date:  2016-02-12       Impact factor: 8.661

8.  Increases in bioactive lipids accompany early metabolic changes associated with β-cell expansion in response to short-term high-fat diet.

Authors:  Maxim D Seferovic; Christine A Beamish; Rockann E Mosser; Shannon E Townsend; Kirk Pappan; Vincent Poitout; Kjersti M Aagaard; Maureen Gannon
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-08-14       Impact factor: 4.310

Review 9.  Developmental Origins of Common Disease: Epigenetic Contributions to Obesity.

Authors:  Maya Kappil; Robert O Wright; Alison P Sanders
Journal:  Annu Rev Genomics Hum Genet       Date:  2016-05-11       Impact factor: 8.929

Review 10.  Interaction between Metformin, Folate and Vitamin B12 and the Potential Impact on Fetal Growth and Long-Term Metabolic Health in Diabetic Pregnancies.

Authors:  Manon D Owen; Bernadette C Baker; Eleanor M Scott; Karen Forbes
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.